The unidirectional hypoxia-activated prodrug OCT1002 inhibits growth and vascular development in castrate-resistant prostate tumors.
about
The unidirectional hypoxia-activated prodrug OCT1002 inhibits growth and vascular development in castrate-resistant prostate tumors.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
The unidirectional hypoxia-act ...... ate-resistant prostate tumors.
@en
The unidirectional hypoxia-act ...... ate-resistant prostate tumors.
@nl
type
label
The unidirectional hypoxia-act ...... ate-resistant prostate tumors.
@en
The unidirectional hypoxia-act ...... ate-resistant prostate tumors.
@nl
prefLabel
The unidirectional hypoxia-act ...... ate-resistant prostate tumors.
@en
The unidirectional hypoxia-act ...... ate-resistant prostate tumors.
@nl
P2093
P2860
P356
P1433
P1476
The unidirectional hypoxia-act ...... rate-resistant prostate tumors
@en
P2093
Heather Nesbitt
Jenny Worthington
Laurence H Patterson
Paul J Smith
Rachel J Errington
Stephanie R McKeown
P2860
P304
P356
10.1002/PROS.23434
P577
2017-09-24T00:00:00Z